Literature DB >> 31652457

Commentary on: Nomograms based on inflammatory biomarkers for predicting tumor grade and microvascular invasion in stage I/II hepatocellular carcinoma.

Liang Xiao1, Furong Zeng2, Guangtong Deng1.   

Abstract

Some doubts were generated during the reading of nomograms based on inflammatory biomarkers for preoperatively predicting tumor grade and microvascular invasion in stage I/II hepatocellular carcinoma (HCC). We would like to highlight and discuss with authors. First, neutrophil-lymphocyte ratio (NLR) and derived NLR (dNLR) should not be entered into multivariate analysis simultaneously. Second, authors should clarify how the cutoffs of these variables including lymphocyte-monocyte ratio (LMR), dNLR, age and tumor size were set. We insist that the type of variables should be consistent when we carry out the analysis and establish the nomogram. Last, we have to point out that Li et al.'s (Biosci. Rep. (2018), 38) study failed to validate nomograms using an independent dataset.
© 2019 The Author(s).

Entities:  

Keywords:  HCC; microvascular invasion; nomogram

Mesh:

Substances:

Year:  2019        PMID: 31652457      PMCID: PMC6822495          DOI: 10.1042/BSR20190683

Source DB:  PubMed          Journal:  Biosci Rep        ISSN: 0144-8463            Impact factor:   3.840


Dear editor, We read with great interest in the recent paper regarding nomograms based on inflammatory biomarkers for preoperatively predicting tumor grade and microvascular invasion in stage I/II hepatocellular carcinoma (HCC) [1]. The nomogram for microvascular invasion plays a pivotal role in clinical decision-making. As we know, microvascular invasion is an extremely important independent risk factor for postoperative recurrence of HCC [2]. Microvascular invasion can not only help clinicians to develop therapeutic schedules after surgery, but also preoperatively guide surgeons on whether to perform liver transplantation beyond Milan Criteria, anatomical liver resection and widening of the surgical margin [3-6]. However, some doubts were generated during the process of reading that we would like to highlight and discuss with authors. First of all, about neutrophil-lymphocyte ratio (NLR) and derived NLR (dNLR). We note that dNLR is composed of neutrophils count divided by white cells count minus neutrophils count. The latter, mixture of monocytes and lymphocytes, is broadly similar to the lymphocytes count. Therefore, dNLR is an alternative for NLR especially when we are not able to get access to lymphocytes count because usually neutrophils and white cells counts are available in clinical database [7]. What is more, studies show that dNLR has similar or inferior prognostic value to the NLR [7,8]. Therefore, it is recommended to choose either one of them to avoid an interaction effect when we analyze the data through multivariate logistic regression [9,10]. However, in Li et al.’s [1] study, NLR and dNLR are entered into multivariate analysis simultaneously. They concluded that not NLR but dNLR is the independent factor of microvascular invasion [1]. We feel that the conclusion of this study should be interpreted with some caution. Second, about the binary variables in nomograms including lymphocyte-monocyte ratio (LMR), dNLR, age and tumor size. It is of note that these variables are analyzed as continuous variables through univariate and multivariate regression. However, these continuous variables were turned into binary variables in nomograms without explanation. Authors should clarify how the cutoffs of these variables were set. In my opinion, it is a wise choice to keep continuous variables in nomograms to avoid the massive information loss just like these papers [11,12]. We insist that the type of variables should be consistent when we carry out the analysis and establish the nomogram. Last, we have to point out that Li et al.’s [1] study failed to validate nomograms using an independent dataset. The validation could help to avoid potential interobserver variability [13]. Also, the nomograms are based on the data from a single center. Thus, we could not conclude whether the nomograms work in other institutes. In conclusion, the present study established practical nomograms for preoperatively predicting tumor grade and microvascular invasion. We hope that the authors can respond to our doubts and this will promote the predictive models.
  13 in total

1.  Prognostic nomograms for prediction of recurrence and survival after curative liver resection for hepatocellular carcinoma.

Authors:  Ju Hyun Shim; Mi-Jung Jun; Seungbong Han; Young-Joo Lee; Sung-Gyu Lee; Kang Mo Kim; Young-Suk Lim; Han Chu Lee
Journal:  Ann Surg       Date:  2015-05       Impact factor: 12.969

2.  The impact of resection margin and microvascular invasion on long-term prognosis after curative resection of hepatocellular carcinoma: a multi-institutional study.

Authors:  Jun Han; Zhen-Li Li; Hao Xing; Han Wu; Peng Zhu; Wan Yee Lau; Ya-Hao Zhou; Wei-Min Gu; Hong Wang; Ting-Hao Chen; Yong-Yi Zeng; Meng-Chao Wu; Feng Shen; Tian Yang
Journal:  HPB (Oxford)       Date:  2019-02-02       Impact factor: 3.647

3.  Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatitis B Virus-Related Hepatocellular Carcinoma Within the Milan Criteria.

Authors:  Zhengqing Lei; Jun Li; Dong Wu; Yong Xia; Qing Wang; Anfeng Si; Kui Wang; Xuying Wan; Wan Yee Lau; Mengchao Wu; Feng Shen
Journal:  JAMA Surg       Date:  2016-04       Impact factor: 14.766

4.  Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis.

Authors:  Vincenzo Mazzaferro; Josep M Llovet; Rosalba Miceli; Sherrie Bhoori; Marcello Schiavo; Luigi Mariani; Tiziana Camerini; Sasan Roayaie; Myron E Schwartz; Gian Luca Grazi; René Adam; Peter Neuhaus; Mauro Salizzoni; Jordi Bruix; Alejandro Forner; Luciano De Carlis; Umberto Cillo; Andrew K Burroughs; Roberto Troisi; Massimo Rossi; Giorgio E Gerunda; Jan Lerut; Jacques Belghiti; Ilka Boin; Jean Gugenheim; Fedja Rochling; Bart Van Hoek; Pietro Majno
Journal:  Lancet Oncol       Date:  2008-12-04       Impact factor: 41.316

5.  Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition).

Authors:  Jian Zhou; Hui-Chuan Sun; Zheng Wang; Wen-Ming Cong; Jian-Hua Wang; Meng-Su Zeng; Jia-Mei Yang; Ping Bie; Lian-Xin Liu; Tian-Fu Wen; Guo-Hong Han; Mao-Qiang Wang; Rui-Bao Liu; Li-Gong Lu; Zheng-Gang Ren; Min-Shan Chen; Zhao-Chong Zeng; Ping Liang; Chang-Hong Liang; Min Chen; Fu-Hua Yan; Wen-Ping Wang; Yuan Ji; Wen-Wu Cheng; Chao-Liu Dai; Wei-Dong Jia; Ya-Ming Li; Ye-Xiong Li; Jun Liang; Tian-Shu Liu; Guo-Yue Lv; Yi-Lei Mao; Wei-Xin Ren; Hong-Cheng Shi; Wen-Tao Wang; Xiao-Ying Wang; Bao-Cai Xing; Jian-Ming Xu; Jian-Yong Yang; Ye-Fa Yang; Sheng-Long Ye; Zheng-Yu Yin; Bo-Heng Zhang; Shui-Jun Zhang; Wei-Ping Zhou; Ji-Ye Zhu; Rong Liu; Ying-Hong Shi; Yong-Sheng Xiao; Zhi Dai; Gao-Jun Teng; Jian-Qiang Cai; Wei-Lin Wang; Jia-Hong Dong; Qiang Li; Feng Shen; Shu-Kui Qin; Jia Fan
Journal:  Liver Cancer       Date:  2018-06-14       Impact factor: 11.740

6.  A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer.

Authors:  M J Proctor; D C McMillan; D S Morrison; C D Fletcher; P G Horgan; S J Clarke
Journal:  Br J Cancer       Date:  2012-07-24       Impact factor: 7.640

7.  A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients.

Authors:  G Absenger; J Szkandera; M Pichler; M Stotz; F Arminger; M Weissmueller; R Schaberl-Moser; H Samonigg; T Stojakovic; A Gerger
Journal:  Br J Cancer       Date:  2013-07-02       Impact factor: 7.640

8.  Derived neutrophil to lymphocyte ratio predicts prognosis for patients with HBV-associated hepatocellular carcinoma following transarterial chemoembolization.

Authors:  Dongsheng Zhou; Jianzhong Liang; L I Xu; Fengying He; Zhongguo Zhou; Yaojun Zhang; Minshan Chen
Journal:  Oncol Lett       Date:  2016-03-21       Impact factor: 2.967

9.  Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.

Authors:  Jia-Zhou Ye; Jun-Ze Chen; Zi-Hui Li; Tao Bai; Jie Chen; Shao-Liang Zhu; Le-Qun Li; Fei-Xiang Wu
Journal:  World J Gastroenterol       Date:  2017-11-07       Impact factor: 5.742

10.  Nomograms based on inflammatory biomarkers for predicting tumor grade and micro-vascular invasion in stage I/II hepatocellular carcinoma.

Authors:  Peng Li; Wei Huang; Feng Wang; Ye-Fang Ke; Lin Gao; Ke-Qing Shi; Meng-Tao Zhou; Bi-Cheng Chen
Journal:  Biosci Rep       Date:  2018-11-13       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.